Cargando…

Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis

OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xia, Bao, Wei, Liu, Jun, OuYang, Ying-Ying, Wang, Di, Rong, Shuang, Xiao, Xiao, Shan, Zhi-Lei, Zhang, Yan, Yao, Ping, Liu, Lie-Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526249/
https://www.ncbi.nlm.nih.gov/pubmed/23264288
http://dx.doi.org/10.2337/dc12-0702
_version_ 1782253528454004736
author Wang, Xia
Bao, Wei
Liu, Jun
OuYang, Ying-Ying
Wang, Di
Rong, Shuang
Xiao, Xiao
Shan, Zhi-Lei
Zhang, Yan
Yao, Ping
Liu, Lie-Gang
author_facet Wang, Xia
Bao, Wei
Liu, Jun
OuYang, Ying-Ying
Wang, Di
Rong, Shuang
Xiao, Xiao
Shan, Zhi-Lei
Zhang, Yan
Yao, Ping
Liu, Lie-Gang
author_sort Wang, Xia
collection PubMed
description OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17–1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16–1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes.
format Online
Article
Text
id pubmed-3526249
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35262492014-01-01 Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis Wang, Xia Bao, Wei Liu, Jun OuYang, Ying-Ying Wang, Di Rong, Shuang Xiao, Xiao Shan, Zhi-Lei Zhang, Yan Yao, Ping Liu, Lie-Gang Diabetes Care Meta-Analysis OBJECTIVE: There has been growing evidence that inflammatory markers play a role in the development of type 2 diabetes. We aimed to systematically review prospective studies on the associations of elevated levels of interleukin-6 (IL-6) and C-reactive protein (CRP) with increased risk of type 2 diabetes by conducting a meta-analysis. RESEARCH DESIGN AND METHODS: A systematic search of the PubMed, EMBASE, ISI Web of Knowledge, and Cochrane Library databases up until 10 February 2012 was conducted to retrieve prospective studies matched to search terms. We used generalized least-squares trend estimation to assess dose-response relationships. The summary risk estimates were pooled using either fixed-effects or random-effects models to incorporate between-study variation. RESULTS: The meta-analysis, including 10 prospective studies, with a total of 19,709 participants and 4,480 cases, detected a significant dose-response association of IL-6 levels with type 2 diabetes risk (relative risk [RR] 1.31 [95% CI 1.17–1.46]). For CRP, the meta-analysis involving 22 cohorts, with a total of 40,735 participants and 5,753 cases, showed that elevated CRP levels were significantly associated with increased risk of type 2 diabetes (1.26 [1.16–1.37]), with the absence of publication bias. Sensitivity and subgroup analyses further supported the associations. CONCLUSIONS: This meta-analysis provides further evidence that elevated levels of IL-6 and CRP are significantly associated with increased risk of type 2 diabetes. American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526249/ /pubmed/23264288 http://dx.doi.org/10.2337/dc12-0702 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Meta-Analysis
Wang, Xia
Bao, Wei
Liu, Jun
OuYang, Ying-Ying
Wang, Di
Rong, Shuang
Xiao, Xiao
Shan, Zhi-Lei
Zhang, Yan
Yao, Ping
Liu, Lie-Gang
Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title_full Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title_fullStr Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title_full_unstemmed Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title_short Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
title_sort inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis
topic Meta-Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526249/
https://www.ncbi.nlm.nih.gov/pubmed/23264288
http://dx.doi.org/10.2337/dc12-0702
work_keys_str_mv AT wangxia inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT baowei inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT liujun inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT ouyangyingying inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT wangdi inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT rongshuang inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT xiaoxiao inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT shanzhilei inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT zhangyan inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT yaoping inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis
AT liuliegang inflammatorymarkersandriskoftype2diabetesasystematicreviewandmetaanalysis